Brief Article
Copyright ©2010 Baishideng.
World J Gastroenterol. Feb 7, 2010; 16(5): 625-630
Published online Feb 7, 2010. doi: 10.3748/wjg.v16.i5.625
Figure 1
Figure 1 Comparison of thymosin β4 levels (μg/mL) between ACLF, CLF, cirrhosis, chronic hepatitis B patients and healthy volunteers. ACLF: Acute-on-chronic liver failure; CLF: Chronic liver failure.
Figure 2
Figure 2 Receiver operating characteristics curve. A: Liver failure patients; B: ACLF patients.
Figure 3
Figure 3 Thymosin β4 levels in non-survivors and survivors of liver failure patients.
Figure 4
Figure 4 Median (inter-quartile range, IQR) thymosin β4 values (μg/mL) observed in 13 liver failure patients.
Figure 5
Figure 5 Serial thymosin β4 concentrations in 6 patients with liver failure.